Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...
Di condition of our lungs fit reveal many tins about our wider health. Luckily, you fit also get dem into beta shape.
Sales of bioAffinity's CyPath® Lung test for lung cancer reached a new high in Q3 2025, representing a 95% increase over the ...
bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced sales of its CyPath ® Lung ...
Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...
CNW/ - Dalhousie University, in collaboration with Nova Scotia Health's INSPIRED COPD Outreach Program, the Nova Scotia ...
When interfaced with a DAQ backbone, spirometer outputs can be captured concurrently with other physiological signals, enabling integrated analysis of respiratory function in correlation with heart ...
TipRanks on MSN
bioAffinity Technologies Presents at CHEST 2025 Conference
Affinity Technologies, Inc. ( (BIAF) ) has provided an announcement. On October 20, 2025, bioAffinity Technologies announced its participation in CHEST 2025, where they will present research ...
Mercy Health Occupational Health Services has a new home in Warren. The facility is now located at E. Market St.
Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as ...
One in five Albertans live with a lung condition, yet access to critical testing is limited in many rural and remote communities. This lack of access can contribute to delayed diagnosis and less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results